Marked Decrease in Serum HDL Cholesterol Levels by Combined Probucol-Pravastatin Treatment in Hypercholesterolemic NIDDM Patients

Ikeda, Tadasu

doi:10.2337/diacare.16.5.849

Article navigation

Letters| May 01 1993

Marked Decrease in Serum HDL Cholesterol Levels by Combined Probucol-Pravastatin Treatment in Hypercholesterolemic NIDDM Patients

Tadasu Ikeda, MD

First Department of Internal Medicine, Tottori University School of Medicine

Yonago, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address Correspondence to Tadasu Ikeda, MD, The First Department of Internal Medicine, Tottori University School of Medicine, Nishi-Machi 36-1 , Yonago 683, Japan.

Diabetes Care 1993;16(5):849–850

https://doi.org/10.2337/diacare.16.5.849

PubMed:

8495635

Marked Decrease in Serum HDL Cholesterol Levels by Combined Probucol-Pravastatin Treatment in Hypercholesterolemic NIDDM Patients

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Marked Decrease in Serum HDL Cholesterol Levels by Combined Probucol-Pravastatin Treatment in Hypercholesterolemic NIDDM Patients Free

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

Marked Decrease in Serum HDL Cholesterol Levels by Combined Probucol-Pravastatin Treatment in Hypercholesterolemic NIDDM Patients